20-methyleholanthrene in arachis oil, to the females of the inbred strain of Wistar rats, aged 3 to 9 months at the time of injection. Tumours all became palpable between the 10th and 26th week after injection.
Where first generation tumour isotransplants were used, the passage was carried out by the subcutaneous implantation of a small piece of tumour (around g. weight) . Tumours were measured daily and the mean of 2 diameters at right angles recorded. The majority of these animals were killed when the tumour had reached 4 cm. mean diameter, but some were killed earlier than this. On killing the animals the tumour was removed; tumour weight and body weight were obtained separately; the spleen was removed, weighed and kept for histology; and a mesenteric lymph node and a liver biopsy taken for histology. Tables 11 and III show the distribution of spleen weights against tumour size of primary and isotransplanted methylcholanthrene tumours. A tendency to increase in spleen size with increasing tumour size is seen. In Table IV Symes (1965 Symes ( , 1966 The experiments of Symes (1965, 1966) on the spleen changes associated with tumour growth, after tumour passage in normal and immuno-suppressed animals, argue strongly in favour of splenomegaly being a reaction to the presence of tumour specific antigen. If this hypothesis is accepted, it would appear from our experimental findings that neither the duration of exposure to antigen nor the antigenic gap between donor and recipient is the major factor in the magnitude of the splenomegaly. Rather a product of foreign antigen and of some other factor, is
